Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 160

Sort by

Sort Order Select

Journal Articles

Triple-hit lymphoma with hyperbasophilic Burkitt-like morphology and solely bone marrow/leukemic phase presentation

Francisco J. Ortuño, Maria-Luz Amigo

Blood (2020) 136 (10): 1212.

https://doi.org/10.1182/blood.2020007134

Published: 2020

Journal Articles

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

David M. Kurtz, MD PhD, Joanne Soo, MD, Stefan Alig, MD, Lyron Co Ting Keh, Charles Macaulay, Michael C. Jin, BS, Florian Scherer, MD, Emily G. Hamilton, BS, Chih Long Liu, PhD, Binbin Chen, PhD, Alexander F. M. Craig, MPhil, Maximilian Diehn, MD PhD, Ash A. Alizadeh, MD PhD

Blood (2019) 134 (Supplement_1): 552.

https://doi.org/10.1182/blood-2019-131267

Published: 2019

Journal Articles

Prognostic Impact of the Baseline Immunologic Profile in Patients with Aggressive B Non-Hodgkin Lymphomas

Safaa M. Ramadan, PhD MD, Giusy Ceparano, MD, Alessandro Cignetti, MD PhD, Simona Sammassimo, MD, Vincenzo Bagnardi, Eleonora Pagan, Daniela Gottardi, MD, Stefano Fiori, MD, Rita Passerini, Tommaso Radice, MD, Giuseppe Saglio, MD, Corrado Tarella, MD

Blood (2019) 134 (Supplement_1): 1522.

https://doi.org/10.1182/blood-2019-132237

Published: 2019

Journal Articles

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

Juan Carlos Ramos, MD BS, Joseph Sparano, MD, Page C. Moore, PhD, Eric Siegel, Jeannette Y Lee, PhD, Erin G. Reid, MD MS, Richard F. Ambinder, MD, Amy Chadburn, MD, Paul G. Rubinstein, MD, Christine Durand, Ethel Cesarman, MD PhD, Lee Ratner, MD PhD, Robert A Baiocchi, MD PhD, David M. Aboulafia, MD, Lawrence D Kaplan, MD, Adam Capoferri, Ronald T. Mitsuyasu, MD, Ariela Noy, MD

Blood (2019) 134 (Supplement_1): 1588.

https://doi.org/10.1182/blood-2019-129687

Published: 2019

Journal Articles

A French Multicentric Prospective Cohort of 6000 Patients with Integrative Epidemiological, Clinical, Biological and Treatment Data to Improve Knowledge on Outcome of Lymphoma Patients: Pilot Phase Results of the Real World Data in Lymphoma and Survival in Adults (REALYSA) Study

Herve Ghesquieres, MD PhD, Cedric Rossi, MD PhD, Fanny Cherblanc, PhD, Sandra Le Guyader, PhD, Fontanet Bijou, MD, Pierre Sujobert, MD PhD, Pascale Fabbro-Peray, MD PhD, Luc Mathieu Fornecker, MD PhD, Adeline Bernier, PhD, Isabelle Baldi, MD PhD, Krimo Bouabdallah, MD, Camille Laurent, MD PhD, Lucie Oberic, MD, Nadine Morineau, MD, Gilles A. Salles, MD PhD, Loic Ysebaert, MD PhD, Alain Monnereau, MD PhD

Blood (2019) 134 (Supplement_1): 4762.

https://doi.org/10.1182/blood-2019-129204

Published: 2019

Journal Articles

Dose Reduction or Omission of Vinca Alkaloids during Initial Chemotherapy Treatment Does Not Impact Outcomes in Patients with Lymphoma

Neelam Mistry, MD, Diana Abbott, PhD, Japera Walker Wilkison, MA, Ajay Major, MDMBA, Brad M. Haverkos, MDMPH,MS, Manali Kamdar, MD

Blood (2019) 134 (Supplement_1): 4126.

https://doi.org/10.1182/blood-2019-129208

Published: 2019

Journal Articles

Clinical, Immunophenotypic and Genetic Characteristics of Aggressive (non-Burkitt) B-Cell Lymphoma in a Real Life Cohort

Blood (2019) 134 (Supplement_1): 4122.

https://doi.org/10.1182/blood-2019-123259

Published: 2019

Journal Articles

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Anja Feldmann, PhD, Stefanie Koristka, PhD, Claudia Arndt, PhD, Liliana Raquel Loureiro, PhD, Ralf Bergmann, PhD, Nicole Berndt, PhD, Anja Hoffmann, Justyna Jureczek, Nicola Mitwasi, Martin Bornhaeuser, MD, Václav Hořejší, Michael Bachmann, MD

Blood (2019) 134 (Supplement_1): 5612.

https://doi.org/10.1182/blood-2019-128193

Published: 2019

Journal Articles

Characteristics of Patients with Relapsed/Refractory Burkitt Non-Hodgkin Lymphoma (NHL): Impact on the Feasibility of CAR-T Cell Therapy

Sonia Fortin Gamero, MD, Yi Lin, MD PhD, Saad S. Kenderian, MD, N. Nora Bennani, MD, Gita Thanarajasingam, MD, Thomas M. Habermann, MD, Grzegorz Nowakowski, MD, Thomas E. Witzig, MD

Blood (2019) 134 (Supplement_1): 5352.

https://doi.org/10.1182/blood-2019-131080

Published: 2019

Journal Articles

Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients

Cole Sterling, MD, Nina D. Wagner-Johnston, MD, Douglas E Gladstone, MD, Richard F. Ambinder, MD, Lode J. Swinnen, MB ChB, Philip Hollingsworth Imus, MD

Blood (2019) 134 (Supplement_1): 3342.

https://doi.org/10.1182/blood-2019-126253

Published: 2019

Journal Articles

Risk of Post-Transplant Lymphoproliferative Disorders (PTLD) in Solid Organ Transplantation Patients with EBV Viremia

Yazeed Sawalha, MD, John McMichael, PhD, Lisa Rybicki, MS, Tamara A. Sussman, MD, Alex V. Mejia Garcia, MD, Robert M. Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH

Blood (2018) 132 (Supplement 1): 4202.

https://doi.org/10.1182/blood-2018-99-114686

Published: 2018

Journal Articles

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

Mengyao Wang, MD, Ying Qu, PhD, Zhiyong Qian, PhD, Ting Niu, MD PhD

Blood (2018) 132 (Supplement 1): 4181.

https://doi.org/10.1182/blood-2018-99-119151

Published: 2018

Journal Articles

Preliminary Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Kami J. Maddocks, MD, Farrukh T. Awan, MD MS, Ying Huang, MA, MS, Sabarish Ayyappan, MBBS, Robert A Baiocchi, MD PhD, Narendranath Epperla, MD MS, Samantha Jaglowski, MD MPH, Basem M. William, MRCP, MD, Kristie A. Blum, MD, Beth A. Christian, MD

Blood (2018) 132 (Supplement 1): 4185.

https://doi.org/10.1182/blood-2018-99-117172

Published: 2018

Journal Articles

Autologous Stem Cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous Therapy and Histological Subtype

Alessandro Re, MD, Nicola Bianchetti, Chiara Cattaneo, MD, Salvatore Casari, MD, Chiara Pagani, MD, Annalisa Peli, MD, Emanuele Focà, MD, Pierino ferremi Leali, MD, Camillo Almici, MD, Francesco Castelli, MD, Giuseppe Rossi

Blood (2018) 132 (Supplement 1): 2145.

https://doi.org/10.1182/blood-2018-99-116816

Published: 2018

Journal Articles

Ultra Deep Whole Exome Sequencing of Classical Hodgkin Lymphoma (cHL) Reveals Novel Recurrent Somatic Mutations

Felicia Gomez, PhD, Kilannin Krysiak, PhD, Cody Ramirez, BS, Eric J. Duncavage, MD, Zachary Skidmore, MEng, Grace Triska, BS, Lee Trani, BA, Nancy L. Bartlett, MD, Amanda F. Cashen, MD, Neha Mehta-Shah, MD, Brad S Kahl, MD, Friederike Kreisel, MD, Malachi Griffith, PhD, Todd A. Fehniger, MDPhD, Obi Griffith

Blood (2017) 130 (Supplement 1): 2733.

https://doi.org/10.1182/blood.V130.Suppl_1.2733.2733

Published: 2017

Journal Articles

Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival

Jean L. Koff, MD, Jingxia Li, Xinyan A. Zhang, PhD MPH, Jeffrey M. Switchenko, PhD MS, Christopher Flowers, MD, Edmund K. Waller, MD

Blood (2017) 130 (Supplement 1): 1578.

https://doi.org/10.1182/blood.V130.Suppl_1.1578.1578

Published: 2017

Journal Articles

CD19-Chimeric Antigen Receptor (CAR) Engineered Natural Killer (NK) Cell Therapy: Novel "Off the Shelf" Immunotherapy in CD20 Resistant B-Cell Non-Hodgkin Lymphoma (NHL) Cell Lines, Primary NHL Cells, and a Human Lymphoma Xenograft Model

Sneha Purvey, MD, Ravi Dashnamoorthy, PhD, Afshin Beheshti, PhD, Andreas Klein, MD, Laurent Boissel, PhD, Saheli Sarkar, PhD, Tali Konry, PhD, Andrew M Evens, DO,MSc

Blood (2017) 130 (Supplement 1): 110.

https://doi.org/10.1182/blood.V130.Suppl_1.110.110

Published: 2017

Journal Articles

Interim PET-CT Result Is Not Predictive of Survival in Patients with MYC -Rearranged Non-Burkitt Aggressive B Cell Lymphoma

Hua-Jay J. Cherng, MD, Rachel Lynn Sargent, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD, Anthony R. Mato, MD, April Schrank-Hacker, Jennifer J.D. Morrissette, PhD, Daniel J. Landsburg, MD

Blood (2017) 130 (Supplement 1): 4136.

https://doi.org/10.1182/blood.V130.Suppl_1.4136.4136

Published: 2017

Journal Articles

A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation

Michael D Jain, PhD MD, Ryan Lam, Rashmi S Goswami, MD, Krystyna Tybinkowski, Parneet K Cheema, MD, Atul Humar, MD MSc, Richard Tsang, MD, David Hodgson, MD, Anca Prica, MD, Vishal Kukreti, MD, Michael Crump, MD, John Kuruvilla, MD

Blood (2016) 128 (22): 4227.

https://doi.org/10.1182/blood.V128.22.4227.4227

Published: 2016

Journal Articles

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Keisuke Kataoka, MD PhD, Hiroaki Miyoshi, MD PhD, Yasunori Kogure, MD, Yasuharu Sato, MD PhD, Kenji Nishida, MD, Yuichi Shiraishi, PhD, Hiroko Tanaka, BA, Kenichi Chiba, BA, Yosaku Watatani, MD, Yusuke Shiozawa, MD, Kenichi Yoshida, MD PhD, Masashi Sanada, MD PhD, Motohiro Kato, MD PhD, Satoru Miyano, PhD, Koji Izutsu, MD PhD, Kengo Takeuchi, MD PhD, Tadashi Yoshino, MD PhD, Koichi Ohshima, MD PhD, Seishi Ogawa, MD PhD

Blood (2016) 128 (22): 4105.

https://doi.org/10.1182/blood.V128.22.4105.4105

Published: 2016

NARROW

Triple-hit lymphoma with hyperbasophilic Burkitt-like morphology and solely bone marrow/leukemic phase presentation

Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA

Prognostic Impact of the Baseline Immunologic Profile in Patients with Aggressive B Non-Hodgkin Lymphomas

A Randomized Trial of EPOCH-Based Chemotherapy with Vorinostat for Highly Aggressive HIV-Associated Lymphomas: Updated Results Evaluating Impact of Diagnosis-to-Treatment Interval (DTI) and Pre-Protocol Systemic Therapy on Outcomes

A French Multicentric Prospective Cohort of 6000 Patients with Integrative Epidemiological, Clinical, Biological and Treatment Data to Improve Knowledge on Outcome of Lymphoma Patients: Pilot Phase Results of the Real World Data in Lymphoma and Survival in Adults (REALYSA) Study

Dose Reduction or Omission of Vinca Alkaloids during Initial Chemotherapy Treatment Does Not Impact Outcomes in Patients with Lymphoma

Clinical, Immunophenotypic and Genetic Characteristics of Aggressive (non-Burkitt) B-Cell Lymphoma in a Real Life Cohort

Development of Novel Anti-CD10 Target Modules for Redirection of Universal CAR T Cells Against CD10-Positive Malignancies

Characteristics of Patients with Relapsed/Refractory Burkitt Non-Hodgkin Lymphoma (NHL): Impact on the Feasibility of CAR-T Cell Therapy

Allogenic Stem Cell Transplantation for Secondary CNS Lymphoma: A Retrospective Review of 21 Patients

Risk of Post-Transplant Lymphoproliferative Disorders (PTLD) in Solid Organ Transplantation Patients with EBV Viremia

Methotrexate-Loaded Biodegradable Polymeric Micelles for Lymphoma Therapy in Mouse Model

Preliminary Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Autologous Stem Cell Transplantation Is Effective in Chemosensitive HIV-Associated Lymphoma Irrespective of Previous Therapy and Histological Subtype

Ultra Deep Whole Exome Sequencing of Classical Hodgkin Lymphoma (cHL) Reveals Novel Recurrent Somatic Mutations

Impact of Post-Transplant Lymphoproliferative Disorder Subtype on Survival

CD19-Chimeric Antigen Receptor (CAR) Engineered Natural Killer (NK) Cell Therapy: Novel "Off the Shelf" Immunotherapy in CD20 Resistant B-Cell Non-Hodgkin Lymphoma (NHL) Cell Lines, Primary NHL Cells, and a Human Lymphoma Xenograft Model

Interim PET-CT Result Is Not Predictive of Survival in Patients with MYC -Rearranged Non-Burkitt Aggressive B Cell Lymphoma

A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation

Structural Variations Involving Programmed Death Ligands in B-Cell and T-Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only